Last reviewed · How we verify

NCT05413252

Team-based Care to Improve Hypertension

Active, enrolled NA Last updated 5 July 2024
What this trial tests

NA trial testing Practice Facilitation in Hypertension in 90 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
31 January 2023
Primary endpoint
30 September 2025
31 December 2027

Quick facts

Lead sponsorNew York University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingnone
Primary purposehealth services research
Enrollment90
Start date31 January 2023
Primary completion30 September 2025
Estimated completion31 December 2027
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

New York University

Who can join

18 and older, any sex, with Hypertension or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a stepped-wedge cluster randomized control trial to compare the effect of Practice Facilitation in 90 small-to-medium sized independent primary care practices on the adoption of team-based care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Facilitation of team-based care to improve HTN management and outcomes: a protocol for a randomized stepped wedge trial.
    Shelley DR, Brown D, Cleland CM, Pham-Singer H, et al · · 2023 · PMID 37259081 · DOI 10.1186/s12913-023-09533-1

Verify or expand the search:

Other trials of Practice Facilitation

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other New York University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05413252.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing